Sriram Ryali - 14 Mar 2022 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc.

Role
Chief Financial Officer
Signature
/s/ Sriram Ryali
Issuer symbol
N/A
Transactions as of
14 Mar 2022
Net transactions value
-$12,683
Form type
4
Filing time
14 Mar 2022, 21:22:50 UTC
Previous filing
11 Mar 2022
Next filing
25 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EIGR Common Stock Sale $12,683 -2,266 -5.2% $5.60 41,566 14 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 14, 2022 for 5,417 shares.